GSTM1 and lung carcinoma: The value of the Hb/RDW ratio as a prognostic measure was evaluated in lung cancer, upper tract urothelial carcinoma, esophageal carcinoma, renal cell cancer, bladder cancer, gastric carcinoma, lymphoma, head and neck cancer, breast cancer, and nasopharyngeal cancer.